AsiaNet Daily Summary - Press Releases for Wednesday, October 26, 2011

SYDNEY--26 Oct--AsiaNet/InfoQuest


WITHDRAWAL ANNOUNCED...

INDIANAPOLIS: Eli Lilly and Company (NYSE: LLY) announces withdrawal of its

Xigris(R) [drotrecogin alfa (activated)] product in all markets following
results of the PROWESS-SHOCK study, which showed the study did not meet the
primary endpoint of a statistically significant reduction in 28-day all-cause
mortality in patients with septic shock.
http://www.lilly.com/
http://bit.ly/sc8n13

INCREASED SHIPMENTS...

SANTIAGO, Chile: From 2006 to 2010, Chilean shipments of food and beverages

to Asia increased by 50%, from US$ 1,865 million in 2006 to US$ 2,801 million
in 2010.
http://bit.ly/u2u8lF

FANNIE MAE REDEMPTION...

WASHINGTON: Fannie Mae (OTC Bulletin Board: FNMA) will redeem the principal

amounts indicated for the following securities issues on the redemption dates
indicated below at a redemption price equal to 100 percent of the principal
amount redeemed, plus accrued interest thereon to the date of redemption.
http://bit.ly/seJpmk

CLOUD INTEGRATION HUB...

TOKYO: Infoteria Corporation, a leader in business integration software for

the Japanese market, made available on October 25 the Cloud Integration Hub
Service "ASTERIA" as an evaluation version for worldwide developers.
http://asteria.com/
http://www.wavemaker.com/
http://bit.ly/uL0gf3

CONTRACTUAL AGREEMENTS...

WELLESLEY HILLS, Mass.: Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for

the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix") revealed today
the contractual agreements for S1P1 lead compounds, AMG 369 and AMG 277,
offered December 8, 2011 in a sealed bid sale.
http://bit.ly/rPssCU

GENETIC ANALYZERS...

CARLSBAD, Calif.: Life Technologies Corporation today announced that its

Applied Biosystems 3500 Dx / 3500xL Dx Genetic Analyzer has been approved by
China's State Food and Drug Administration(SFDA) for diagnostic use in China.
http://www.lifetechnologies.com/
http://bit.ly/sXRPN6

DEPARTMENTAL IT PLAN...

HONG KONG: Unisys Hong Kong has been commissioned by the Hong Kong Food and

Environmental Hygiene Department to conduct a five-year departmental IT plan
(DITP).
http://www.unisys.com/
http://www.unisys.com.hk/
http://bit.ly/ubivMM

NEW STANDARD...

PRAGUE, Czech Republic: JetBrains, the creators of intelligent,

productivity-enhancing development tools, extends its wide range of
technology-specific development environments with AppCode - a new IDE for
Objective-C developers.
http://www.jetbrains.com/
http://bit.ly/unzFfo

HAUTE COUTURE SHOW...

BEIJING: The Tang Dynasty is considered to be the most prosperous time in

Chinese history, when the country's civilization achieved its greatest heights.
http://bit.ly/rVgdzr

REGISTRATIONS OPEN...

COPENHAGEN, Denmark: On 1 October, The VELUX Group launched the

International VELUX Award 2012 to encourage and challenge students of
architecture all over the world to explore and investigate daylight in
architecture.
http://www.velux.com/
http://bit.ly/uUjDGo

RESILIENCY PREPARATION...

SINGAPORE and BANGKOK: As the worst floods in over 50 years continues to

affect Thailand, Marsh, the world's leading insurance broker and risk advisor,
outlines steps that businesses should take to help them prepare before and
during the emergency.
http://www.marsh.com/
http://www.mmc.com/
http://www.guycarp.com/
http://www.mercer.com/
http://www.oliverwyman.com/ow/index.html
http://bit.ly/v2NqP3

LINE-HONOURS...

SINGAPORE: The Audi ultra finished the VinaCapital Hong Kong to Vietnam Race

2011 (19-21 October) with line-honours -- the first-ever Singapore registered
yacht to manage this, following its line-honours victory in the previous week's
China Coast Regatta in Hong Kong.
http://bit.ly/ujF9wo

24-HOUR CUSTOMER SERVICE...

THE WOODLANDS, Texas: On Center Software [ http://www.oncenter.com/index.html

], the first name in construction software, today announced the firm has
enhanced its Customer Service [ http://www.oncenter.com/support/index.html ]
platform to run 24 hours every business day.
http://bit.ly/rGFIHn

AsiaNet is a consortium of leading news agencies distributing unedited,

translated news releases for worldwide clients.

Visit www.asianetnews.net for full-text versions.


ข่าวEli Lilly and Company+o:asnวันนี้

Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs

On July 13, 2022, Triastek, Inc. ("Triastek") announced a collaboration with Eli Lilly and Company ("Lilly"), a leading global pharmaceutical company, to leverage the advantages of 3D printing technology to enable precisely targeted and programmed release of drugs in specific regions of the GI tract. According to the agreement, the project will focus on the targeted release of drugs in the intestine. Triastek will focus on two aspects: Firstly, conduct an in-depth study of excipient properties

New Data Show Lilly's Once-Weekly Trulicity(R) (dulaglutide) Solution for Injection is Effective as Add-on Treatment to Sulfonylurea

Trulicity 1.5 mg Demonstrates Superior Efficacy in AWARD-8 Trial New data from a completed Phase 3 trial show Trulicity(R) (dulaglutide) solution for injection 1.5 mg...

Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis

Once-daily oral baricitinib significantly improved all seven components of ACR response versus injectable adalimumab Patient-reported pain, joint stiffness, fatigue and physical...

European Commission Approves Trulicity(R) (dulaglutide) Solution for Injection, Lilly's Once-Weekly, Ready-to-Use Type 2 Diabetes Treatment

Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the only non-insulin, injectable diabetes treatment available in a pen with a no-see, no-handle...

Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries

Significant portion of alliance opportunity will remain unchanged; some countries will transition to exclusive promotion in 2015 In a move that will strengthen their alliance by enhancing...

European Commission grants Lilly and Boehringer Ingelheim's insulin glargine product marketing authorisation in Europe

First biosimilar insulin to receive regulatory approval in the EU The European Commission (EC) granted marketing authorisation for Eli Lilly and Company and Boehringer Ingelheim's...

CHMP Recommends Lilly and Boehringer Ingelheim's New Insulin Glargine Product for Approval in the European Union

First biosimilar insulin to receive CHMP positive opinion in the EU The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the...

Studies Show Investigational New Insulin Glargine Product from Lilly and Boehringer Ingelheim Similar in Safety and Efficacy to Lantus(R)

Companies present comprehensive data for LY2963016, new insulin glargine product For the first time today, Eli Lilly and Company and Boehringer Ingelheim presented...

Lilly and Alzheimer's Disease International Partner to Address Barriers that Impact the Accurate and Timely Diagnosis of Alzheimer's Disease

New educational resources to help patients and caregivers communicate vital information with physicians are released as global leaders meet to discuss the...

Eli Lilly and Company and Boehringer Ingelheim announce new drug application filing in the U.S. for new insulin glargine product

New Drug Application follows submission of Marketing Authorisation Application to the European Medicines Agency Eli Lilly and Company and Boehringer Ingelheim today...